BBNX (Beta Bionics) Total Operating Expense: $140.3 Mil (TTM As of Mar. 2026)


BBNX Beta Bionics Inc BBNX
10 GF Score
Price $17.20
! 3 Warning Signs
View Full Analysis

What is Beta Bionics Total Operating Expense?

Beta Bionics BBNX +1.00% 10 Total Operating Expense is $140.3 Mil as of Mar. 2026. GuruFocus rates BBNX with a GF Score™ of 10/100. The stock has 3 warning signs investors should review.

Beta Bionics's Total Operating Expense for the three months ended in Mar. 2026 was $40.7 Mil. Beta Bionics's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $140.3 Mil.

Beta Bionics Total Operating Expense Related Terms

Beta Bionics Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Beta Bionics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Bionics Total Operating Expense Chart

Beta Bionics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Operating Expense
66.02 42.16 81.14 127.22

Beta Bionics Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 27.61 32.38 32.16 35.07 40.71
BBNX
10GF Score
Beta Bionics Inc BBNX
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beta Bionics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $140.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $140.3 Mil mean?
Beta Bionics (BBNX) has a Total Operating Expense of $140.3 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Beta Bionics and its competitors.
Is Beta Bionics' Total Operating Expense too high?
Beta Bionics' current Total Operating Expense is $140.3 Mil. Overall, Beta Bionics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Beta Bionics' Total Operating Expense compare to CBLL and SIBN?
Beta Bionics' Total Operating Expense of $140.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Beta Bionics and its competitors. Beta Bionics's current Total Operating Expense is $140.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Bionics stock overvalued right now?
Beta Bionics (BBNX) has a current Total Operating Expense of $140.3 Mil. The current Total Operating Expense is $140.3 Mil. Beta Bionics' overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Beta Bionics (BBNX), the current Total Operating Expense is $140.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beta Bionics Business Description

Address 11 Hughes, Irvine, CA, USA, 92618
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
10GF Score

Get the complete analysis for BBNX

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.20
Price